Hydroxyapatite: An alternative method of frontal sinus obliteration

Carl H. Snyderman, K. E N Scioscia, Ricardo L. Carrau, Jane Weissman

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Surgical obliteration of the frontal sinus has been approached in many ways over the past 100 years. The search for the ideal implant material continues. In contrast to alloplastic materials, HAC is biocompatible and allows osseointegration. It is easily sculpted to fill irregular defects. There is no exothermic reaction that could injure adjacent tissues. Potential donor site morbidity associated with the use of autogenous tissue is avoided. Clinical experience with HAC with follow-up as long as 6 years demonstrates its safety, efficacy, and stability. Greater experience is needed to explore its limitations and develop new applications. In the future, the physicochemical properties and degree of osseointegration of the HAC may be modulated with the addition of antibiotics or growth factors.

Original languageEnglish (US)
Pages (from-to)179-191
Number of pages13
JournalOtolaryngologic Clinics of North America
Volume34
Issue number1
DOIs
StatePublished - 2001

Fingerprint

Osseointegration
Frontal Sinus
Durapatite
Intercellular Signaling Peptides and Proteins
Anti-Bacterial Agents
Morbidity
Safety

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Hydroxyapatite : An alternative method of frontal sinus obliteration. / Snyderman, Carl H.; Scioscia, K. E N; Carrau, Ricardo L.; Weissman, Jane.

In: Otolaryngologic Clinics of North America, Vol. 34, No. 1, 2001, p. 179-191.

Research output: Contribution to journalArticle

Snyderman, Carl H. ; Scioscia, K. E N ; Carrau, Ricardo L. ; Weissman, Jane. / Hydroxyapatite : An alternative method of frontal sinus obliteration. In: Otolaryngologic Clinics of North America. 2001 ; Vol. 34, No. 1. pp. 179-191.
@article{b92ac9d80bc241a1ac64175540d98edb,
title = "Hydroxyapatite: An alternative method of frontal sinus obliteration",
abstract = "Surgical obliteration of the frontal sinus has been approached in many ways over the past 100 years. The search for the ideal implant material continues. In contrast to alloplastic materials, HAC is biocompatible and allows osseointegration. It is easily sculpted to fill irregular defects. There is no exothermic reaction that could injure adjacent tissues. Potential donor site morbidity associated with the use of autogenous tissue is avoided. Clinical experience with HAC with follow-up as long as 6 years demonstrates its safety, efficacy, and stability. Greater experience is needed to explore its limitations and develop new applications. In the future, the physicochemical properties and degree of osseointegration of the HAC may be modulated with the addition of antibiotics or growth factors.",
author = "Snyderman, {Carl H.} and Scioscia, {K. E N} and Carrau, {Ricardo L.} and Jane Weissman",
year = "2001",
doi = "10.1016/S0030-6665(05)70305-4",
language = "English (US)",
volume = "34",
pages = "179--191",
journal = "Otolaryngologic Clinics of North America",
issn = "0030-6665",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Hydroxyapatite

T2 - An alternative method of frontal sinus obliteration

AU - Snyderman, Carl H.

AU - Scioscia, K. E N

AU - Carrau, Ricardo L.

AU - Weissman, Jane

PY - 2001

Y1 - 2001

N2 - Surgical obliteration of the frontal sinus has been approached in many ways over the past 100 years. The search for the ideal implant material continues. In contrast to alloplastic materials, HAC is biocompatible and allows osseointegration. It is easily sculpted to fill irregular defects. There is no exothermic reaction that could injure adjacent tissues. Potential donor site morbidity associated with the use of autogenous tissue is avoided. Clinical experience with HAC with follow-up as long as 6 years demonstrates its safety, efficacy, and stability. Greater experience is needed to explore its limitations and develop new applications. In the future, the physicochemical properties and degree of osseointegration of the HAC may be modulated with the addition of antibiotics or growth factors.

AB - Surgical obliteration of the frontal sinus has been approached in many ways over the past 100 years. The search for the ideal implant material continues. In contrast to alloplastic materials, HAC is biocompatible and allows osseointegration. It is easily sculpted to fill irregular defects. There is no exothermic reaction that could injure adjacent tissues. Potential donor site morbidity associated with the use of autogenous tissue is avoided. Clinical experience with HAC with follow-up as long as 6 years demonstrates its safety, efficacy, and stability. Greater experience is needed to explore its limitations and develop new applications. In the future, the physicochemical properties and degree of osseointegration of the HAC may be modulated with the addition of antibiotics or growth factors.

UR - http://www.scopus.com/inward/record.url?scp=0035043464&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035043464&partnerID=8YFLogxK

U2 - 10.1016/S0030-6665(05)70305-4

DO - 10.1016/S0030-6665(05)70305-4

M3 - Article

C2 - 11344072

AN - SCOPUS:0035043464

VL - 34

SP - 179

EP - 191

JO - Otolaryngologic Clinics of North America

JF - Otolaryngologic Clinics of North America

SN - 0030-6665

IS - 1

ER -